The bilirubin analyzers market is projected to grow from USD 555.4 million in 2026 to USD 1,004.0 million by 2036, at a CAGR of 6.8%. Transcutaneous Bilirubin Meters will dominate with a 58.0% market share, while hospital procurement will lead the sales channel segment with a 64.0% share.